SABSW vs UNP · P/E 0.0 vs P/E 21, rev $6.86B
SAB Biotherapeutics Inc (SABSW) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
SABSW does not have a complete income-statement cache yet.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
SABSW currently screens at market cap $0 and trailing P/E 0.0. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the SABSW and UNP stock pages for the full models.
Not investment advice.